University of the Region of Joinville Reports Findings in Hemodialysis (Comparison of 1-year survival between patients initiating chronic hemodialysis under public and private health insurance: register-based data analysis from Brazil): Dialysis – Hemodialysis

2024 APR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- New research on Dialysis - Hemodialysis is the subject of a report. According to news reporting out of Santa Catarina, Brazil, by NewsRx editors, research stated, “Brazil has one of the world’s highest numbers of patients on hemodialysis (HD). Most dialysis centers are private and perform HD for patients with private and public health insurance.”

Our news journalists obtained a quote from the research from the University of the Region of Joinville, “We compared 1-year survival between patients initiating chronic HD with public and private health insurance. This is an HD register-based retrospective cohort. Adult patients starting HD from January 2011 to December 2021 were included. Survival analysis was stratified according to the period entered in the HD register. Multivariate Cox regression focused on 1-year survival differences between private and public patients. In the final sample (n = 5114), 68.5% of participants had public and 31.3% to private health insurance, with overall 1-year survival of 92.8% and 89.9%, respectively (p = 0.002). Crude analysis showed a slightly higher survival rate among patients with public health insurance than those with private health insurance (91 vs. 87%, p = 0.030) in the first period (2019-21). However, the adjusted hazard ratio (HR) did not remain significantly higher for patients with private health insurance compared to those with public health insurance (HR = 1.07; 95% CI 0.80-1.41; p = 0.651), even after propensity score matching of the groups by several baseline features.”

According to the news editors, the research concluded: “Brazilian chronic HD patients funded by either private health plans or the public system have a similar 1-year mortality risk after controlling for several sociodemographic and clinical parameters.”

This research has been peer-reviewed.

For more information on this research see: Comparison of 1-year survival between patients initiating chronic hemodialysis under public and private health insurance: register-based data analysis from Brazil. International Urology and Nephrology, 2024. International Urology and Nephrology can be contacted at: Springer, Van Godewijckstraat 30, 3311 Gz Dordrecht, Netherlands. (Springer - www.springer.com; International Urology and Nephrology - http://www.springerlink.com/content/0301-1623/)

Our news journalists report that additional information may be obtained by contacting Helbert do Nascimento Lima, Medicine Department, University of the Region of Joinville (Univille), Rua Rio do Sul 270, Joinville, Santa Catarina, 89202-201, Brazil. Additional authors for this research include Joel Monarrez-Espino, Fabiana Baggio Nerbass, Jose A. Moura-Neto, Ricardo Sesso and Jocemir Ronaldo Lugon.

Publisher contact information for the journal International Urology and Nephrology is: Springer, Van Godewijckstraat 30, 3311 Gz Dordrecht, Netherlands.

(Our reports deliver fact-based news of research and discoveries from around the world.)